Cardiovascular Disease Protection Tissue

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 28, 2018

Study Completion Date

September 28, 2018

Conditions
Myocardial Ischemia
Interventions
PROCEDURE

Heart failure or coronary disease

Small samples collected from the apex core in the heart. In addition, blood samples will be taken.

PROCEDURE

Heart transplant patients

Heart samples collected including, excess myocardial biopsy samples. In addition, blood samples will be taken.

PROCEDURE

Orthotopic Heart Transplant Patients

Myocardial tissue samples collected from the diseased heart. In addition, blood samples will be taken.

PROCEDURE

Heart Surgery Patients

Heart samples will be collected from the left atrial appendages. In addition, blood samples will be taken.

PROCEDURE

Blood Draw

All subjects will have 20 ml of blood drawn for further analysis.

Trial Locations (1)

32610

Yanfei Qi, Gainesville

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Florida

OTHER

NCT02348515 - Cardiovascular Disease Protection Tissue | Biotech Hunter | Biotech Hunter